BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28877559)

  • 1. An instrumented timed up and go in facioscapulohumeral muscular dystrophy.
    Huisinga J; Bruetsch A; Mccalley A; Currence M; Herbelin L; Jawdat O; Pasnoor M; Dimachkie M; Barohn R; Statland J
    Muscle Nerve; 2018 Mar; 57(3):503-506. PubMed ID: 28877559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of the responsiveness of wireless motion analysis in facioscapulohumeral muscular dystrophy.
    Statland JM; Karanevich A; Bruetsch A; Huisinga J
    Muscle Nerve; 2019 Nov; 60(5):590-594. PubMed ID: 31443130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy.
    Eichinger K; Heatwole C; Heininger S; Stinson N; Matichak Stock C; Grosmann C; Wagner KR; Tawil R; Statland JM;
    Muscle Nerve; 2017 Mar; 55(3):333-337. PubMed ID: 27421252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment.
    Aprile I; Padua L; Iosa M; Gilardi A; Bordieri C; Frusciante R; Russo G; Erra C; De Santis F; Ricci E
    Eur J Phys Rehabil Med; 2012 Sep; 48(3):393-402. PubMed ID: 22713540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical impedance myography in facioscapulohumeral muscular dystrophy.
    Statland JM; Heatwole C; Eichinger K; Dilek N; Martens WB; Tawil R
    Muscle Nerve; 2016 Oct; 54(4):696-701. PubMed ID: 26840230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait propulsion in patients with facioscapulohumeral muscular dystrophy and ankle plantarflexor weakness.
    Rijken NH; van Engelen BG; de Rooy JW; Weerdesteyn V; Geurts AC
    Gait Posture; 2015 Feb; 41(2):476-81. PubMed ID: 25687333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
    Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
    Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balance and walking involvement in facioscapulohumeral dystrophy: a pilot study on the effects of custom lower limb orthoses.
    Aprile I; Bordieri C; Gilardi A; Lainieri Milazzo M; Russo G; De Santis F; Frusciante R; Iannaccone E; Erra C; Ricci E; Padua L
    Eur J Phys Rehabil Med; 2013 Apr; 49(2):169-78. PubMed ID: 23138679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Functional Capacity Testing in Patients With Facioscapulohumeral Muscular Dystrophy: Construct Validity and Interrater Reliability of Antigravity Tests.
    Rijken NH; van Engelen BG; Weerdesteyn V; Geurts AC
    Arch Phys Med Rehabil; 2015 Dec; 96(12):2201-6. PubMed ID: 26363336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facioscapulohumeral muscular dystrophy functional composite outcome measure.
    Eichinger K; Heatwole C; Iyadurai S; King W; Baker L; Heininger S; Bartlett A; Dilek N; Martens WB; Mcdermott M; Kissel JT; Tawil R; Statland JM
    Muscle Nerve; 2018 Jan; ():. PubMed ID: 29381807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
    Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
    Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
    Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
    Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.
    LoRusso S; Johnson NE; McDermott MP; Eichinger K; Butterfield RJ; Carraro E; Higgs K; Lewis L; Mul K; Sacconi S; Sansone VA; Shieh P; van Engelen B; Wagner K; Wang L; Statland JM; Tawil R;
    BMC Neurol; 2019 Sep; 19(1):224. PubMed ID: 31506080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).
    Mul K; Hamadeh T; Horlings CGC; Tawil R; Statland JM; Sacconi S; Corbett AJ; Voermans NC; Faber CG; van Engelen BGM; Merkies ISJ
    Eur J Neurol; 2021 Jul; 28(7):2339-2348. PubMed ID: 33838063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instrumented balance and walking assessments in persons with multiple sclerosis show strong test-retest reliability.
    Craig JJ; Bruetsch AP; Lynch SG; Horak FB; Huisinga JM
    J Neuroeng Rehabil; 2017 May; 14(1):43. PubMed ID: 28532417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal detectable changes of the Berg Balance Scale, Fugl-Meyer Assessment Scale, Timed "Up & Go" Test, gait speeds, and 2-minute walk test in individuals with chronic stroke with different degrees of ankle plantarflexor tone.
    Hiengkaew V; Jitaree K; Chaiyawat P
    Arch Phys Med Rehabil; 2012 Jul; 93(7):1201-8. PubMed ID: 22502805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the inertial sensor-based Timed "Up and Go" test in individuals affected by stroke.
    Wüest S; Massé F; Aminian K; Gonzenbach R; de Bruin ED
    J Rehabil Res Dev; 2016; 53(5):599-610. PubMed ID: 27898161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy.
    Gidaro T; Gasnier E; Annoussamy M; Vissing J; Attarian S; Mozaffar T; Iyadurai S; Wagner KR; Vissière D; Walker G; Shukla SS; Servais L
    Muscle Nerve; 2022 Feb; 65(2):237-242. PubMed ID: 34687225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isokinetic assessment of trunk muscles in facioscapulohumeral muscular dystrophy type 1 patients.
    Esnault J; Missaoui B; Bendaya S; Mane M; Eymard B; Laforet P; Stojkovic T; Behin A; Thoumie P
    Neuromuscul Disord; 2018 Dec; 28(12):996-1002. PubMed ID: 30415787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trunk muscle involvement is most critical for the loss of balance control in patients with facioscapulohumeral muscular dystrophy.
    Rijken NH; van Engelen BG; de Rooy JW; Geurts AC; Weerdesteyn V
    Clin Biomech (Bristol, Avon); 2014 Sep; 29(8):855-60. PubMed ID: 25156185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.